LEO Pharma presents late-breaking abstracts for temtokibart reporting positive Phase 2b (efficacy, safety, biomarker) results ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...

I am very lucky to travel for my work. It's something I love to do and which has filled my life with eye-opening experiences and encounters. One aspect of my travel that I don't love is what it does ...

The Cigna Group (NYSE: CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera ...

Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...

Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...

As children return to school, common skin conditions that were previously under control may flare up once again, thanks to a ...

Dupixent, which Sanofi jointly developed and co-owns with drugmaker Regeneron, is approved not only for eczema but also for ...